AntineoplasticsNeutropenic fevers, mucositis and hand-foot syndrome: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1739卷 / 1期

关键词：

D O I：

10.1007/s40278-019-57678-6

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：38 / 38

相关论文

共 50 条

[21] SorafenibGrade 3 hand-foot syndrome: case report
Reactions Weekly, 2017, 1674 (1) : 280 - 280
[22] LenvatinibPyoderma gangrenosum and hand-foot syndrome: case report
Reactions Weekly, 2021, 1861 (1) : 180 - 180
[23] SunitinibHypertension, glossitis and hand-foot syndrome: case report
Reactions Weekly, 2017, 1677 (1) : 245 - 245
[24] LenvatinibPneumothorax, hand-foot syndrome and proteinuria : case report
Reactions Weekly, 2018, 1701 (1) : 176 - 176
[25] PazopanibMild hand-foot syndrome and fatigue: case report
Reactions Weekly, 2018, 1724 (1) : 290 - 290
[26] SunitinibHypertension, hand-foot syndrome and hypothyreosis: case report
Reactions Weekly, 2015, 1539 (1) : 271 - 271
[27] RivoceranibHypertension, proteinuria and hand-foot syndrome: case report
Reactions Weekly, 2018, 1716 (1) : 249 - 249
[28] AntineoplasticsMyelosuppression, hand-foot syndrome and rash: case report
Reactions Weekly, 2018, 1702 (1) : 32 - 32
[29] Encorafenib/NivolumabPsoriasis and hand-foot syndrome: case report
Reactions Weekly, 2025, 2044 (1) : 134 - 134
[30] SorafenibAsthenia, diarrhoea and hand-foot syndrome: case report
Reactions Weekly, 2013, 1454 (1) : 39 - 39

← 1 2 3 4 5 →